BDTX 株価推移チャート
BDTX 株価予測
Black Diamond Therapeutics Inc
$2.86
1.06%
$0.02
終値： May 13, 16:00:00 GMT-4
$2.86
0.02%
$0
プレマーケット： May 14, 04:36:35 GMT-4
戻る
Black Diamond Therapeutics Inc (BDTX) 株価予測
主要データ
前終値
$2.83
始値
$2.82
当日レンジ
$2.8 - $2.87
52週レンジ
$1.53 - $4.94
取引高
485.5K
平均取引高
789.5K
配当利回り
--
1株当たり利益(TTM)
0.38
時価総額
$163.8M
BDTXとは何ですか？
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 21 full-time employees. The company went IPO on 2020-01-30. The Company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat central nervous system disease. The firm is advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. Its BDTX-4933 pipeline product is out-licensed to Servier. BDTX-4933 is designed to target RAS and RAF alterations in solid tumors. The company is exploring partnership opportunities for its FGFR2/3 selective development candidate BDTX-4876.
